Bottom line
XSMO vs RYWAX: the short answer
XSMO (Invesco S&P SmallCap Momentum ETF) and RYWAX (S&P SmallCap 600 Pure Growth Fund) are quite different portfolios: only about 27% of their top holdings (by weight) are shared.
XSMO is cheaper at 0.35% vs 1.54% — a difference of $119 a year per $10,000 invested.
Over five years, XSMO returned +9.6% a year vs +2.9% for RYWAX.
Updated Nov 19, 2026
XSMO vs RYWAX side by side
| XSMO | RYWAX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Guggenheim |
| Category | Small-Cap | Small-Cap |
| Expense ratio | 0.35% | 1.54% |
| Annual cost per $10k | $35 | $154 |
| 10-yr cost on $10k (prospectus) | $444 | $1,885 |
| Max front load | None | — |
| 12b-1 fee | — | 0.25% |
| 1-yr return | +9.8% | +8.6% |
| 5-yr return (annualized) | +9.6% | +2.9% |
| 10-yr return (annualized) | +12.3% | +6.6% |
| Best quarter | +23.7% | +31.3% |
| Worst quarter | −25.2% | −35.3% |
| Net assets (fund) | $3.0B | $60.7M |
| Number of holdings | 110 | 129 |
| Portfolio turnover | 121% | 1,133% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XSMO | RYWAX | Difference |
|---|---|---|---|
| 2025 | +9.8% | +8.6% | +1.2% |
| 2024 | +17.6% | +8.1% | +9.5% |
| 2023 | +21.4% | +17.9% | +3.6% |
| 2022 | −15.5% | −29.9% | +14.4% |
| 2021 | +19.3% | +18.9% | +0.4% |
| 2020 | +21.8% | +16.1% | +5.8% |
| 2019 | +28.3% | +12.4% | +15.9% |
| 2018 | −2.9% | −8.9% | +6.1% |
| 2017 | +23.4% | +16.1% | +7.3% |
| 2016 | +7.2% | +18.4% | −11.2% |
Source: Fund prospectus bar charts
Holdings overlap
9 of XSMO's top 25 holdings also appear in RYWAX's top 25.
| Holding | XSMO | RYWAX |
|---|---|---|
| Viasat, Inc. | 4.59% | 1.37% |
| Protagonist Therapeutics, Inc. | 2.57% | 1.59% |
| StoneX Group Inc. | 2.17% | 1.66% |
| Ligand Pharmaceuticals Inc. | 1.88% | 1.23% |
| ACM Research, Inc. | 1.78% | 3.80% |
| Powell Industries, Inc. | 1.76% | 2.05% |
| MYR Group Inc. | 1.59% | 1.48% |
| Enova International, Inc. | 1.52% | 1.47% |
| PTC Therapeutics, Inc. | 1.43% | 1.41% |
Source: SEC Form N-PORT
XSMO top 10
- Invesco Private Prime Fund — 11.81%
- Viasat, Inc. — 4.59%
- Invesco Private Government Fund — 4.51%
- ESCO Technologies Inc. — 2.97%
- Protagonist Therapeutics, Inc. — 2.57%
- Indivior Pharmaceuticals, Inc. — 2.20%
- Mercury Systems, Inc. — 2.17%
- StoneX Group Inc. — 2.17%
- FormFactor, Inc. — 1.98%
- Ligand Pharmaceuticals Inc. — 1.88%
RYWAX top 10
- Acm Research Inc — 3.80%
- Powell Industries Inc — 2.05%
- Argan Inc — 2.04%
- Dave Inc — 1.85%
- Stonex Group Inc — 1.66%
- Protagonist Therapeutics Inc — 1.59%
- Sphere Entertainment Company — 1.56%
- Clear Secure Inc — 1.54%
- Alignment Healthcare Inc — 1.53%
- Liquidia Corp — 1.51%
FAQ
What is the difference between XSMO and RYWAX?
Which is cheaper, XSMO or RYWAX?
Should I own both XSMO and RYWAX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.